FDA Provides Emergency-Use Status for Abbott’s $ 5 COVID-19 Rapid Antigen Test

The US Food and Drug Administration has granted Abbott Laboratories an emergency use authorization for a $ 5 rapid-response COVID-19 antigen test that is roughly the size of a credit card.
The low cost, rapid response test can be administered in a doctor’s or school nurse’s office and uses the same technology as a home pregnancy test. This results in about 15 minutes.

Emergency approval comes as demand for more access to COVID-19 diagnostic tools increases, which results in minutes rather than days to help infections quickly.
Abbott Abt,
+ 0.70%
With plans to ramp up production to 50 million in September, Wednesday said it plans to ship tens of new approved tests in September. If the company were able to do so, the total number of tests conducted in the US in July would almost double in October.

Some public-health officials and laboratory officials say that low-cost rapid tests that can be mass-produced are an important factor in the nation’s ability to work and return to school.
An expanded version of this report appears on WSJ.com.
Also popular on WSJ.com:
Donald Trump presides over the GOP remake in his image.
Wisconsin identified the officer who shot Jacob Blake.


Leave a Reply

Your email address will not be published.